Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04134572Recruiting

Registry of Ollier Disease and Maffucci Syndrome

Role: lead

NCT04115774Recruiting

Registry of Osteogenesis Imperfecta

Role: lead

NCT05247645Recruiting

Data Collection of Patients With Rare Bone Diseases

Role: lead

NCT04133272Recruiting

Registry of Ehlers-Danlos Syndrome

Role: lead

NCT04133285Recruiting

Registry of Multiple Osteochondromas

Role: lead

All 5 trials loaded